FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Nutropin AQ Nuspin 10 (somatropin) by Genentech, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Idiopathic Short Stature
• Prader-willi Syndrome
• Small For Gestational Age
• Turner Syndrome

Drugs mentioned

• NUTROPIN AQ NUSPIN 10 (somatropin)

Snippet

SUPPL AP for NUTROPIN AQ NUSPIN 10 (SOMATROPIN)